ACELRX PHARMACEUTICALS INC (43) | Business Finance (11)
Browse by Subcategory
Recent Contracts
-
Second Amendment to Loan and Security Agreement between the Registrant and Oxford Finance, LLC, dated as of November 14, 2021
(Filed With SEC on March 10, 2022)
-
Contingent Value Rights Agreement, dated as of January7, 2022, by and among AcelRx Pharmaceuticals, Inc., James Wilkie, solely in his capacity as the representative of the Lowell...
(Filed With SEC on January 12, 2022)
-
Form of Warrant
(Filed With SEC on November 15, 2021)
-
Purchase Agreement between the Company and the Purchasers, dated November 15, 2021
(Filed With SEC on November 15, 2021)
-
Description of Capital Stock
(Filed With SEC on March 15, 2021)
-
Underwriting Agreement
(Filed With SEC on January 21, 2021)
-
First Amendment to Loan and Security Agreement, dated as of May 5, 2021, between Oxford Finance, LLC and the Registrant
(Filed With SEC on November 15, 2021)
-
Purchase Agreement between the Company and the Purchasers, dated July 22, 2020
(Filed With SEC on July 23, 2020)
-
Description of Capital Stock
(Filed With SEC on March 16, 2020)
-
Form of Warrant to Purchase Common Stock of the Registrant, dated as of May 30, 2019
(Filed With SEC on June 3, 2019)
-
Loan and Security Agreement with Oxford Finance LLC, dated as of May 30, 2019
(Filed With SEC on June 3, 2019)
